Hot High Dividend Stocks To Buy Right Now


J.P. Morgan Chase & Co. is promoting Michael Millman and Jeff Zajkowski to co-heads for Americas equity capital markets, which encompasses underwriting IPOs and other stock offerings, according to an internal memo.

Mr. Millman, 43, who was previously head of technology, media and telecom equity capital markets, will remain based in San Francisco, where he will continue to oversee TMT equity offerings globally. Mr. Zajkowski, 48, who was head of ECM for the Asia-Pacific region, will move from Hong Kong to New York.


The appointments come ahead of one of the biggest and most anticipated U.S. IPOs in years, for Chinese e-commerce Alibaba Group Holding Ltd., which is expected to raise more than $15 billion; J.P. Morgan is one of the five lead underwriters on the deal, people familiar with the matter have said.

Hot High Dividend Stocks To Buy Right Now: Computer Task Group Inc (CTG)

Computer Task Group, Incorporated (CTG), incorporated on March 11, 1966, is an information technology (IT) solutions and staffing company with operations in North America and Europe. CTG provides IT services to its clients, which includes IT Solutions and IT Staffing. During the year ended December 31, 2011, the Company had six operating subsidiaries: Computer Task Group of Canada, Inc., providing services in Canada; and Computer Task Group Belgium N.V., CTG ITS S.A., Computer Task Group IT Solutions, SA., Computer Task Group Luxembourg PSF, and Computer Task Group (U.K.) Ltd., each were providing services in Europe. Services provided in North America are performed by CTG. It provides services to all of the markets, which it serves. The services provided encompass the IT business solution life cycle, including phases for planning, developing, implementing, managing, and maintaining the IT solution. In February 2013, it acquired etrinity from i-Cros Nv of Antwerp, Belgium.


The Company promotes its services through four vertical market focus areas: technology service providers; healthcare, which includes services provided to healthcare providers, health insurers (payers), and life sciences companies; energy, and financial services. At December 31, 2011, CTG provided IT services to approximately 300 clients in North America and Europe. In North America, the Company operates in the United States and Canada. In Europe, the Company operates in Belgium, Luxembourg, and the United Kingdom.

IT Solutions

CTG’s services in IT solution area include helping clients assess their business needs and identifying the IT solutions. The services delivered by the Company include the selection and implementation of packaged software and the design, development, testing, and integration of new systems, and the development and implementation of customized software and solutions designed to fit the needs of a specific clien t or vertical market. Also included in IT Solutions is Trans! itional Application Management (TAM).


In 2011, the healthcare market accounted for most of CTG’s TAM business. In 2011, CTG continued to invest in new IT solutions development, primarily targeted to the healthcare market, which support cost reductions and productivity improvements. In 2011, several healthcare solutions under development moved from the pilot stage of testing using live data into the sales process as completed tools. These solutions include medical fraud, waste, and abuse detection and reduction, medical care and disease management, and group insurance underwriting risk assessment. The Company has developed software to support these offerings. These solutions support both the healthcare provider and payer markets.


IT Staffing

The Company recruits, retains, and manages IT talent for its clients, which are technology service providers and companies with multiple locations and need for external IT resources. The Company also supports companies and organizations that need to augment their own IT staff on a flexible basis. It provides IT talent services on a temporary or long-term basis. CTG’s recruiting organization works with customers to define their staffing requirements. The primary focus of the Company’s staffing business is a managed services model that provides clients with support through supply models customized to client needs, resource management support, vendor management programs, and a automated recruiting process and system. During 2011, its IT staffing service generated 63% of its total revenue.


Advisors’ Opinion:

  • [By Seth Jayson]

    Computer Task Group (Nasdaq: CTG  ) reported earnings on July 22. Here are the numbers you need to know.

    The 10-second takeaway
    For the quarter ended June 28 (Q2), Computer Task Group missed estimates on revenues and met expectations on earnings per share.

Hot High Dividend Stocks To Buy Right Now: SandRidge Mississippian Trust I (SDT)

SandRidge Mississippian Trust I (The Trust) is a statutory trust. The Trust was created to acquire and hold the Royalty Interests for the benefit of Trust unitholders. SandRidge conveyed to the Trust the Royalty Interests in specified oil and natural gas properties in the Mississippian formation in Alfalfa, Garfield, Grant, Major and Woods counties in Oklahoma (the Underlying Properties). These Royalty Interests were derived from SandRidge’s interests in a 36 wells and the equivalent of 123 horizontal development wells to be drilled in the Mississippian formation (Trust Development Wells) within an area of mutual interest (AMI), consisting of approximately 49,600 gross acres (42,000 net acres) in the counties where the Underlying Properties are located.


Effective January 1, 2011, the Royalty Interests entitle the Trust to receive 90% of the proceeds from the sale of oil and natural gas production attributable to its net revenue interest in the Initial Wells and 50% of the proceeds from the sale of oil and natural gas production attributable to SandRidge’s net revenue interest in the Trust Development Wells. As of December 31, 2011, the Trust’s properties consisted of Royalty Interests in the Initial Wells, 48 wells (equivalent to approximately 53 Trust Development Wells under the development agreement) and the equivalent of approximately 70 Trust Development Wells to be drilled in the Mississippian formation.


Advisors’ Opinion:

  • [By Matt DiLallo]

    The problem here is that SandRidge has been dependent on asset sales and its running out of assets to sell. In addition to the Permian sale, SandRidge has now taken three royalty trusts public. One consisting of Permian Basin assets, SandRidge Permian Trust (NYSE: PER  ) and two consisting of Mississippian assets, SandRidge Mississippian Trust I (NYSE: SDT  ) and SandRidge Mississippian Trust II (NYSE: SDR  ) . While SandRidge still owns a portion of each trust, it likely will continue to sell off its ownership stake in each trust as well as other assets it still owns. At some point SandRidge will need to live within its oil and gas cash flows, otherwise, its not worth owning. 

  • [By Dan Caplinger]

    SandRidge has made a huge bet on the Mississippian Lime shale play, especially after selling off its Permian Basin assets late last year. Unfortunately, that bet hasn’t paid off well for shareholders, as the company saw its spun-off royalty trusts SandRidge Mississippian Trust I (NYSE: SDT  ) and SandRidge Mississippian Trust II (NYSE: SDR  ) fail to meet their projections for distribution amounts during the first quarter. The main problem has been that wells in the Mississippian Lime have produced more natural gas than expected, and even with a slight rebound in gas prices, it still doesn’t produce adequate margins compared to oil and natural-gas liquids.

  • [By Matt DiLallo]

    SandRidge Mississippian Trust I (NYSE: SDT  ) and Trust II (NYSE: SDR  )
    These trusts were created by SandRidge Energy (NYSE: SD  ) , with the first Mississippian Trust formed in 2010 and the second formed one year later. Both trusts own royalty interests in oil and gas properties targeting the Mississippian formation and have future upside as SandRidge drills wells as part of the areas of mutual interest.

Hot High Dividend Stocks To Buy Right Now: Kohlberg Capital Corporation(KCAP)

Kohlberg Capital Corporation is a private equity and venture capital firm specializing in buyouts and mezzanine investments. It focuses on mature and middle market companies. The firm structures its investments through senior debt, second lien debt, secured and unsecured subordinated debt, mezzanine debt, and equity. It invests in all sectors except cyclical industries. The firm invests equity in both minority and control transactions alongside other equity investors. It invests through its own balance sheet. Kohlberg Capital Corporation is based in the New York, New York.


Advisors’ Opinion:

  • [By Monica Gerson]

    KCAP Financial (NASDAQ: KCAP) is projected to report its Q4 earnings at $0.25 per share on revenue of $13.27 million.

    Home Inns & Hotels Management (NASDAQ: HMIN) is estimated to post its Q4 earnings at $2.18 per share on revenue of $1.54 billion.

Hot High Dividend Stocks To Buy Right Now: iShares U.S. Healthcare Providers ETF (IHF)

iShares Dow Jones U.S. Health Care Providers Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Health Care Providers Index (the Index). The Index measures the performance of the healthcare providers sector of the United States equity market. The Index includes companies that are healthcare providers, such as owners and operators of health maintenance organizations, hospitals, clinics, dentists, opticians, nursing homes, rehabilitation and retirement centers.


The Fund will concentrate its investments in a particular industry or group of industries to approximately the same extent as the Index is so concentrated. Since all of the securities included in the Index are issued by companies in the healthcare providers sector, the Fund will be concentrated in the healthcare providers industry. The Fund’s investment advisor is Barclays Global Fund Advisors.

Advisors’ Opinion:

  • [By John Udovich]

    Beaten down small cap home care and infusion stock BioScrip Inc (NASDAQ: BIOS) was recently called a potential takeover target, meaning its worth taking a closer look at the stock along with healthcare ETFs like the iShares Dow Jones US Health Care ETF (NYSEARCA: IHF) or the Health Care SPDR ETF (NYSEARCA: XLV). I should mention that during the third quarter of last year, we had BioScrip in our SmallCap Network Elite Opportunity (SCN EO) portfolio after the stock had taken a beating but we also believed the company is on the verge of turning a profit and is potentially undervalued.

  • [By WWW.INVESTMENTNEWS.COM]

    Most advisers are quick to spell out uncorrelated returns as the primary benefit of alternatives but few understand how to conduct comparative analysis. The tendency is to look at the funds’ return and volatility; which starts one off on the wrong path. With alternatives, it’s a two part process in which the first is simply qualification and then the second is measuring the material benefit for your portfolio. The necessary condition is uncorrelated, or non-systemic, returns. Without this, the investor is better off simply selecting a traditional long-only fund with the highest risk-adjusted prospects. Once you have identified a group of uncorrelated funds, the second step involves the tradeoff between return and correlatio

Hot High Dividend Stocks To Buy Right Now: Hancock Holding Company(HBHC)


Hancock Holding Company, a financial holding company, provides various banking and financial services in south Mississippi, Louisiana, South Alabama, and Florida. The company accepts various deposit products that include non-interest bearing demand deposits, NOW account deposits, money market deposits, savings deposits, and time deposits. Its loan portfolio comprises provision of commercial, consumer, commercial leasing, and real estate loans to consumers and small and middle market businesses. Hancock also offers various trust services that include operating as an executor, administrator, or guardian in administering estates; provision of investment custodial services for individuals, businesses, and charitable and religious organizations, as well as investment management services on an agency basis; and trustee services for pension plans, profit sharing plans, corporate and municipal bond issues, living trusts, life insurance trusts, and various other types of trusts cre ated for individuals, businesses, and charitable and religious organizations. In addition, it provides consumer financing services; owns, manages, and maintains real property; offers general insurance agency services; holds investment securities; markets credit life insurance; and engages in discount investment brokerage services, as well as owns approximately 3,700 acres of timber land in Hancock County, Mississippi. The company operates 182 banking and financial services offices and 161 automated teller machines. Hancock Holding Company was founded in 1899 and is headquartered in Gulfport, Mississippi.


Advisors’ Opinion:

  • [By Dividends4Life]

    Fair Value: In calculating fair value, I consider the NPV MMA Differential Fair Value along with these four calculations of fair value, see page 2 of the linked PDF for a detailed description:

    1. Avg. High Yield Price
    2. 20-Year DCF Price
    3. Avg. P/E Price
    4. Graham Number

    CTBI is trading at a premium to all four valuations above. The stock is trading at a 53.5% premium to its calculated fair value of $29.43. CTBI did not earn any Stars in this section.


    Dividend Analytical Data: In this section there are three possible Stars and three key metrics, see page 2 of the linked PDF for a detailed description:

    1. Free Cash Flow Payout
    2. Debt To Total Capital
    3. Key Metrics
    4. Dividend Growth Rate
    5. Years of Div. Growth
    6. Rolling 4-yr Div. > 15%

    CTBI earned one Star in this section for 1.) above. A Star was earned since the Free Cash Flow payout ratio was less than 60% and there were no negative Free Cash Flows over the last 10 years. The company has paid a cash dividend to shareholders every year since 1988 and has increased its dividend payments for 33 consecutive years.


    Dividend Income vs. MMA: Why would you assume the equity risk and invest in a dividend stock if you could earn a better return in a much less risky money market account (MMA) or Treasury bond? This section compares the earning ability of this stock with a high yield MMA. Two items are considered in this section, see page 2 of the linked PDF for a detailed description:

    1. NPV MMA Diff.
    2. Years to > MMA

    The negative NPV MMA Diff. means that on a NPV basis the dividend earnings from an investment in CTBI would be less than a similar amount invested in MMA earning a 20-year average rate of 3.41%. If CTBI grows its dividend at 1.5% per year, it will never equal a MMA yielding an estimated 20-year average rate of 3.41%.


    Memberships and Peers: CTBI is, a member of the Broad Dividend Achieve

  • [By Eric Volkman]

    Hancock Holding (NASDAQ: HBHC  ) is resolutely sticking to its longtime dividend policy. Matching the same common stock payout it’s distributed since September 2006, the financial services concern has declared a distribution of $0.24 per share. This is to be paid on September 16 to shareholders of record as of September 5.

Hot High Dividend Stocks To Buy Right Now: Kirrin Resources Inc (KIRRF.PK)

Kirrin Resources Inc. (Kirrin) is a development-stage company. The Company’s principal business is the acquisition, exploration and development of uranium and rare earth elements resources properties. Kirrin operates two REE properties, Grevet in Quebec and Bottom Brook in Newfoundland and one uranium project, Alexis River, in southeastern Labrador. It holds its property interests through its wholly owned Alberta subsidiary, Kirrin Exploration Inc. (KEI). It has an option agreement with Altius Resources Inc. to earn a minimum 60%, maximum 100% interest in the Alexis River uranium property, located in southeastern Labrador. It has an option agreement with Ucore Rare Metals Inc. to earn a minimum 50%, maximum 65% interest in the Lost Pond/Bottom Brookrare earth elements and uranium property, located in western Newfoundland. It has an option agreement with Michel Proulx to earn a 100% interest over four years in the Grevet rare earth elements property located in northwestern Que bec. Advisors’ Opinion:

  • [By The Gold Report]

    Tickers related to the original interview with Don Mosher include: Teck Resources (TCK) and Kirrin Resources (KIRRF.PK).

    DISCLOSURE:
    1) Streetwise Reports does not accept stock in exchange for its services or as sponsorship payment.
    2) Kevin Campbell: I was not paid by Streetwise Reports for participating in this interview. Comments and opinions expressed are my own comments and opinions and may not represent those of Haywood Securities. I had the opportunity to review the interview for accuracy as of the date of the interview and am responsible for the content of the interview.
    3) Interviews are edited for clarity. Streetwise Reports does not make editorial comments or change experts’ statements without their consent.
    4) The interview does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer.
    5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned and may make purchases and/or sales of those securities in the open market or otherwise.

Hot High Dividend Stocks To Buy Right Now: Pain Therapeutics Inc (PTIE)


Pain Therapeutics, Inc., incorporated in May 1998, is a biopharmaceutical company that develops drugs. The Company has four drug candidates in clinical programs, including REMOXY, abuse-resistant hydromorphone, abuse-resistant hydrocodone and a radio-labeled monoclonal antibody to treat metastatic melanoma. It is also working on a new treatment for patients with hemophilia. The Company’s lead drug candidate is REMOXY, which is a painkiller. It has collaboration agreement with King Pharmaceuticals, Inc (King) develops and commercializes REMOXY and other opioid painkillers. The Company and King jointly managed a Phase III clinical program and New Drug Application (NDA) submission for REMOXY. It is also developing a pipeline of drug candidates in the area of oncology and hematology. It owns all commercial rights to its pipeline of drug candidates in oncology and hematology. As of December 31, 2010, the Company leased approximately 30,700 square feet of space in San Mateo, California and all of its operations are located in San Mateo.


REMOXY

REMOXY is a controlled-release oral capsule form of oxycodone in a highly viscous liquid formulation matrix that includes excipients. It is formulated to help address issues of abuse and misuse of time-release oxycodone tablets. REMOXY’s capsule dosage form provides therapeutic drug levels of oxycodone on a twice-daily dosing schedule, while resisting the rapid increases in plasma levels of oxycodone associated with common methods of abuse and misuse. Its formulation also resists delivery by unapproved routes of administration, such as injection, snorting or inhalation.


Metastatic Melanoma

The Company is developing a drug candidate called PTI-188 to treat metastatic melanoma, a form of skin cancer. PTI-188 is a monoclonal antibody linked to a radioisotope, intended to deliver doses of radiation lethal to melanoma tumors without harming normal tissue. I n March 2010, the Company announced data from two open-label! , dose-escalating Phase I studies conducted in Israel to assess the safety, pharmacokinetics, dosimetry and anti-tumor activity of PTI-188. During the year ended December 31, 2010, the second study was completed. The technology used in this program was developed at the Albert Einstein College of Medicine (AECOM). It had licensed worldwide commercial rights to this technology from AECOM.


Hemophilia

The Company has a gene transfer program, initially developed at Stanford University, focused at correcting a genetic disorder in which patients are unable to stop bleeding. During 2010, it conducted a variety of pre-clinical studies with this technology. The Company has licensed worldwide commercial rights to the technology used in this program from Poetic Genetics, LLC (Poetic).

Other product candidates

The Company’s alliance with King includes development of three other abuse-resistant opioid product candidates: hydromorphone , hydrocodone and oxymorphone. Its abuse-resistant formulations of hydromorphone and hydrocodone have completed Phase I clinical trials. In January 2011, the Company announced that the Food and Drug Administration (FDA) had accepted its investigational IND, for abuse-resistant oxymorphone.


The Company competes with Roxane Laboratories, Purdue Pharma, King Pharmaceuticals, Inc., Abbott Laboratories, Cephalon, Endo Pharmaceuticals, Teva Pharmaceuticals, Elkins-Sinn, Watson Laboratories, Ortho-McNeil Pharmaceutical and Forest Pharmaceuticals.

Advisors’ Opinion:

  • [By Sean Williams]

    However, all isn’t well when it comes to the future of abuse-resistant painkiller Remoxy, which was developed by Pain Therapeutics (NASDAQ: PTIE  ) , using Durect’s special technology-based gel capsule to prevent abuse, and is licensed by Pfizer (NYSE: PFE  ) . Remoxy has been rejected twice by the FDA — the most recent coming in mid-2011 — and Pfizer commented this morning that if it were to seek reapproval for the drug it wouldn’t be for at least two more years. Given Pfizer’s extensive product pipeline, losing Remoxy wouldn’t be a big deal. For micro-cap clinical-stage companies like Pain Therapeutics and Durect, it’d be a gigantic blow. Fittingly, Pain Therapeutics and Durect shares imploded by 50% and 34%, respectively, on Friday.

  • [By Jessica Alling]

    Elsewhere, Pfizer is evaluating its continued partnership on an experimental oxycodone capsule, Remoxy. The drug is an extended-release formula that is targeted at reducing abuse of the painkiller. After years of setbacks and postponements for FDA approval, Pfizer is weighing its options. Its partners for the drug, Pain Therapeutics (NASDAQ: PTIE  ) and Durect, have both fallen heavily due to the news, with Pain Therapeutics falling more than 50% — its largest decline ever.

Hot High Dividend Stocks To Buy Right Now: Calumet Specialty Products Partners L.P.(CLMT)


Calumet Specialty Products Partners, L.P. produces and sells specialty hydrocarbon products in North America. It operates in two segments, Specialty Products and Fuel Products. The Specialty Products segment processes crude oil and other feedstocks into various customized lubricating oils, white mineral oils, solvents, petrolatums, gelled hydrocarbons, cable fillers, natural petroleum sulfonates, waxes, and compressor lubricants. Its products are used in applications in a range of industries, such as industrial goods, including metal working fluids, belts, hoses, sealing systems, batteries, hot melt adhesives, pressure sensitive tapes, electrical transformers, refrigeration compressors, and drilling fluids; consumer goods, including candles, petroleum jelly, creams, tonics, lotions, coating on paper cups, chewing gum base, automotive aftermarket car-care products, lamp oils, charcoal lighter fluids, camping fuel, and various aerosol products; and automotive goods, such as motor oils, greases, transmission fluid, and tires. The Fuel Products segment processes crude oil into various fuel and fuel-related products, such as gasoline, diesel, jet fuel, and heavy fuel oils. This segment also offers fuel-related products, including fluid catalytic cracking feedstock, asphalt vacuum residuals, and mixed butanes. Calumet GP, LLC serves as the general partner for Calumet Specialty Products Partners, L.P. The company was founded in 1916 and is headquartered in Indianapolis, Indiana.


Advisors’ Opinion:

  • [By Robert Rapier]

    Calumet Specialty Products Partners (Nasdaq: CLMT) also reported a net loss for the quarter of $34.8 million, or ($0.54) per diluted unit, compared with net income of $42.4 million, or $0.69 per diluted unit, for the same quarter in 2012. Units traded down nearly 13 percent for the week.

  • [By Ben Levisohn]

    The price of crude oil in the U.S. has dropped nearly 9% during the past month of trading, and Credit Suisse believes it’s time to take another look at the refiners, including Tesoro (TSO) and  Calumet Specialty Products (CLMT).

Hot High Dividend Stocks To Buy Right Now: Mattson Technology Inc.(MTSN)


Mattson Technology, Inc. engages in the design, manufacture, marketing, and support of semiconductor wafer processing equipment used in the fabrication of integrated circuits for the semiconductor industry worldwide. Its dry strip products include the SUPREMA strip system that incorporates its inductively coupled plasma (ICP) technology photoresist process module, and vacuum-based productivity platform for processing of sub 30 nm devices. The company?s rapid thermal processing products include the Helios and Helios XP systems for conventional annealing applications, and the Millios system for millisecond anneal applications. Its etch products comprise the paradigmE and Alpine that feature a proprietary Faraday-shielded ICP with etch bias control to provide process on-wafer performance. The company sells its products directly, as well as through distribution agreements to foundries, and memory and logic device manufacturers. Mattson Technology, Inc. was founded in 1988 and is headquartered in Fremont, California.


Advisors’ Opinion:

  • [By Roberto Pedone]

    Mattson Technology (MTSN) designs, manufactures and markets semiconductor wafer processing equipment used in the fabrication of integrated circuits. This stock closed up 5.1% to $2.25 in Tuesday’s trading session.

    Tuesday’s Range: $2.15-$2.30

    52-Week Range: $0.70-$2.55

    Tuesday’s Volume: 593,000

    Three-Month Average Volume: 825,998

    From a technical perspective, MTSN bounced higher here back above its 50-day moving average at $2.23 with lighter-than-average volume. It looks like MTSN has now put in a double bottom chart pattern, since the stock has found some buying interest over the last month at $2.05 to $2.07. If that bottom can hold, then shares of MTSN will not set up to trigger a major breakout trade. That trade will hit if MTSN manages to take out some near-term overhead resistance levels at $2.40 to $2.52 and then once it clears its 52-week high at $2.55 with high volume.

    Traders should now look for long-biased trades in MTSN as long as it’s trending above $2.07 to $2.05 and then once it sustains a move or close above those breakout levels with volume that hits near or above 825,998 shares. If that breakout hits soon, then MTSN will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are its next major overhead resistance levels at $3.17 to its three-year high at $3.30.

  • [By Stephen Simpson, CFA]

    Ultratech isn’t the only game in town, though, and there are multiple technologies and process steps that are going to play significant roles in the production of FinFETs and 3D circuits. With that, I would take a look at Mattson Technologies (MTSN), as this company has already accomplished the not-so-easy task of gaining meaningful share in the dry strip, rapid thermal processing (RTP), and etch markets despite competing with giants like Lam Research (LRCX), Applied Materials (AMAT), and Tokyo Electron (TOELY.PK).

  • [By Ben Axler]

    In the table below, we’ve listed a sample of small-cap semiconductor capital equipment stocks such as Entegris (ENTG), Advanced Energy Industries (AEIS), ATMI Inc. (ATMI), MKS Instruments (MKSI), Photronics Inc. (PLAB), Rudolph Technologies (RTEC),FormFactor (FORM) and Mattson Technology (MTSN). The peers trade at approximately 1.0x and 15.5x 2014E revenues and EPS, respectively. Furthermore, the average peer trades at 2.1x tangible book value. However, these multiples are based on average 2014E industry revenue and earnings growth of 18% and 119%, respectively. Axcelis is poised to grow at a rate substantially above the industry average.

Hot High Dividend Stocks To Buy Right Now: Gray Fox Petroleum Corp (GFOX)

Gray Fox Petroleum Corp., incorporated on September 22, 2011, is a domestic oil and gas exploration and development company. The Company focuses on the acquisition and exploration of oil and natural gas properties in the Western United States.

The Company has 100% working interest and an 82% net revenue interest in the 32,723 acre West Ranch Prospect. The Company’s West Ranch Prospect is located in the Butte Valley Oil Play Region of north central Nevada in Elko and White Pine Countries, which has produced over 50 million barrels of oil in Nevada from structures and reservoir horizons similar to those under the West Ranch Prospect. The prospect consists of 22 Federal leases in the Butte Valley Oil Play Region.

Advisors’ Opinion:

  • [By Peter Graham]

    On Friday, small cap mining stocks Maverick Minerals Corp (OTCMKTS: MVRM) and Liberty Coal Energy Corp (OTCMKTS: LBTG) plus oil stock Gray Fox Petroleum Corp (OTCBB: GFOX) sank 30.9%, 16.67% and 11.2%, respectively. However, only one of these stocks appears to have been the subject of some kind of paid promotion in the form of an investment in some shares. So will these three small cap mining or oil stocks keep coming up empty for investors this week? Here is a closer look: